Pralatrexate
Pralatrexate | |
---|---|
Term | Pralatrexate |
Short definition | Pralatrexate - (pronounced) (PRA-luh-TREK-sayt) A drug used to treat peripheral T-cell lymphoma (a fast-growing form of non-Hodgkin's lymphoma) that has come back (come back) or has not improved with other cancer therapies. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Pralatrexate - (pronounced) (PRA-luh-TREK-sayt) A drug used to treat peripheral T-cell lymphoma (a fast-growing form of non-Hodgkin's lymphoma) that has come back (come back) or has not improved with other cancer therapies. It is also being studied in the treatment of other types of cancer. Pralatrexate prevents cells from using folic acid to make DNA. This can help prevent cancer cells from growing and kill them. Pralatrexate is a type of antimetabolite and a type of dihydrofolate reductase inhibitor. Also called folotyn
External links
- Medical encyclopedia article on Pralatrexate
- Wikipedia's article - Pralatrexate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski